EP2526397A2 - Numération cellulaire et chambre d'échantillonnage et procédés de fabrication - Google Patents

Numération cellulaire et chambre d'échantillonnage et procédés de fabrication

Info

Publication number
EP2526397A2
EP2526397A2 EP11735090A EP11735090A EP2526397A2 EP 2526397 A2 EP2526397 A2 EP 2526397A2 EP 11735090 A EP11735090 A EP 11735090A EP 11735090 A EP11735090 A EP 11735090A EP 2526397 A2 EP2526397 A2 EP 2526397A2
Authority
EP
European Patent Office
Prior art keywords
layer
sample
chamber
sample chamber
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP11735090A
Other languages
German (de)
English (en)
Other versions
EP2526397B1 (fr
EP2526397A4 (fr
Inventor
Leo L. Chan
Jean Qiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexcelom Bioscience LLC
Original Assignee
Nexcelom Bioscience LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexcelom Bioscience LLC filed Critical Nexcelom Bioscience LLC
Publication of EP2526397A2 publication Critical patent/EP2526397A2/fr
Publication of EP2526397A4 publication Critical patent/EP2526397A4/fr
Application granted granted Critical
Publication of EP2526397B1 publication Critical patent/EP2526397B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C59/00—Surface shaping of articles, e.g. embossing; Apparatus therefor
    • B29C59/02—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing
    • B29C59/021—Surface shaping of articles, e.g. embossing; Apparatus therefor by mechanical means, e.g. pressing of profiled articles, e.g. hollow or tubular articles, beams
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/48—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding
    • B29C65/50—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding using adhesive tape, e.g. thermoplastic tape; using threads or the like
    • B29C65/5057—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding using adhesive tape, e.g. thermoplastic tape; using threads or the like positioned between the surfaces to be joined
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/01—General aspects dealing with the joint area or with the area to be joined
    • B29C66/05—Particular design of joint configurations
    • B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
    • B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
    • B29C66/112—Single lapped joints
    • B29C66/1122—Single lap to lap joints, i.e. overlap joints
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/53—Joining single elements to tubular articles, hollow articles or bars
    • B29C66/534—Joining single elements to open ends of tubular or hollow articles or to the ends of bars
    • B29C66/5346—Joining single elements to open ends of tubular or hollow articles or to the ends of bars said single elements being substantially flat
    • B29C66/53461—Joining single elements to open ends of tubular or hollow articles or to the ends of bars said single elements being substantially flat joining substantially flat covers and/or substantially flat bottoms to open ends of container bodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1429—Signal processing
    • G01N15/1433—Signal processing using image recognition
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1484—Optical investigation techniques, e.g. flow cytometry microstructural devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/0303—Optical path conditioning in cuvettes, e.g. windows; adapted optical elements or systems; path modifying or adjustment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0689—Sealing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0877—Flow chambers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0887—Laminated structure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/48—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding
    • B29C65/4805—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding characterised by the type of adhesives
    • B29C65/481—Non-reactive adhesives, e.g. physically hardening adhesives
    • B29C65/4825—Pressure sensitive adhesives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/48—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding
    • B29C65/4805—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding characterised by the type of adhesives
    • B29C65/483—Reactive adhesives, e.g. chemically curing adhesives
    • B29C65/4835—Heat curing adhesives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/48—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding
    • B29C65/50—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding using adhesive tape, e.g. thermoplastic tape; using threads or the like
    • B29C65/5007—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding using adhesive tape, e.g. thermoplastic tape; using threads or the like characterised by the structure of said adhesive tape, threads or the like
    • B29C65/5021—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding using adhesive tape, e.g. thermoplastic tape; using threads or the like characterised by the structure of said adhesive tape, threads or the like being multi-layered
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/70—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/71—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the composition of the plastics material of the parts to be joined
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2033/00—Use of polymers of unsaturated acids or derivatives thereof as moulding material
    • B29K2033/04—Polymers of esters
    • B29K2033/08—Polymers of acrylic acid esters, e.g. PMA, i.e. polymethylacrylate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2063/00—Use of EP, i.e. epoxy resins or derivatives thereof, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2075/00—Use of PU, i.e. polyureas or polyurethanes or derivatives thereof, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/756—Microarticles, nanoarticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1486—Counting the particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/05—Flow-through cuvettes
    • G01N2021/056—Laminated construction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/05—Flow-through cuvettes
    • G01N2021/058—Flat flow cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/02—Mechanical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49826—Assembling or joining

Definitions

  • the invention generally relates to analytical and monitoring systems useful for analyzing and measuring cells and biological sample. More particularly, the invention relates to a unique sample chamber, e.g., a thin gap fluidic cell counting chamber useful for both bright field and fluorescent imaging of bacteria or parasites, and methods for making and using the same.
  • a unique sample chamber e.g., a thin gap fluidic cell counting chamber useful for both bright field and fluorescent imaging of bacteria or parasites, and methods for making and using the same.
  • Detection, identification, quantification, and characterization of biomolecules or cells of interest through testing of biological samples is an important aspect in the fields of medical diagnostics and biomedical research.
  • Biological solutions such as blood, spinal fluid, cell culture and urine, are routinely analyzed for their microscopic particle concentrations.
  • Bioscience that utilizes a microfluidic counting chamber, which can automatically count cells larger than 2 ⁇ m in diameter.
  • the invention is based, in part, on the discovery of a novel thin gap fluidic chamber design and efficient and cost-effective methods of fabrication and manufacture.
  • a thin gap fluidic sample chamber is required to minimize the effect of multiple imagine planes.
  • the novel fabrication method can be used to create the appropriate chamber gap height.
  • the cell chamber of the invention can be used for both bright field and fluorescent imaging of bacteria, parasites, protein aggregates, or larger mammalian, insect, or plant cell types.
  • the invention generally relates to a sample chamber suitable for holding a liquid sample for optical imaging.
  • the sample chamber includes: a top layer; an adhesive layer; a bottom layer; a sample holding cavity between the adhesive layer and the bottom layer having a fixed depth of from about 0.5 ⁇ m to about 1,000 ⁇ m; and an assess port for placing a sample into or out of the chamber; wherein at least a portion of the adhesive layer is optically clear in the range of about 250 nm to about 10,000 nm in wavelength, and wherein at least a portion of the top layer and the bottom layer is optically clear in the range of about 300 nm and about 10,000 nm in wavelength.
  • the bottom layer of the sample chamber further includes a base film.
  • the sample holding cavity of the sample chamber has a fixed depth of from about 1 ⁇ m to about 100 ⁇ m. In certain preferred embodiments, the sample holding cavity has a fixed depth of from about 2 ⁇ m to about 50 ⁇ m. In certain preferred embodiments, the sample holding cavity has a fixed depth of from about 2 ⁇ m to about 20 ⁇ m. In certain other preferred embodiments, the sample holding cavity has a fixed depth less than about 2 ⁇ m. In certain other preferred embodiments, the sample holding cavity has a fixed depth less than about 1 ⁇ m.
  • At least a portion of the adhesive layer is optically clear in the range of about 300 nm to about 10,000 nm in wavelength, and wherein at least a portion of the top and the bottom layers is optically clear in the range of about 300 nm and about 10,000 nm in wavelength.
  • the top layer of the sample chamber may be made of a material selected from the group consisting of polyester, polycarbonate, poly(methyl methacrylate) (or PMMA), polystyrene and cyclic olefin copolymer, and other optically clear plastic films.
  • the adhesive layer of the sample chamber may be a pressure-sensitive adhesive layer that includes a material selected from acrylic or acrylate adhesive.
  • the bottom layer may include an irradiation or thermally cured material.
  • the bottom layer may be a UV-cured polymeric material.
  • the UV- cured materials are selected from the group consisting of UV-cured acrylate, urethane and epoxy.
  • the sample chamber further includes a backing layer that is bond to the bottom layer.
  • the backing layer may include a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer, and other optically clear plastic films.
  • the invention generally relates to a sample chamber suitable for holding a biological sample for optical imaging.
  • the sample chamber includes: an optically clear bottom layer; an optically clear top layer; an optically clear adhesive layer binding the top layer on one side and forming a sample holding chamber on the other side with an irradiation- or thermally-cured polymer layer, wherein the sample holding chamber having a fixed depth from the adhesive layer to the irradiation- or thermally-cured polymer layer of from about 0.5 ⁇ m to about 1,000 ⁇ m; an inlet port for introducing a sample into the chamber; and an outlet port for removing a sample from the chamber (the sample holding cavity).
  • the sample holding chamber has a fixed depth of from about 1 ⁇ m to about 100 ⁇ m. In certain preferred embodiments, the sample holding chamber has a fixed depth of from about 2 ⁇ m to about 50 ⁇ m. In certain preferred embodiments, the sample holding chamber has a fixed depth of from about 2 ⁇ m to about 20 ⁇ m. In certain other preferred embodiments, the sample holding chamber has a fixed depth of less than about 2 ⁇ m. In certain other preferred embodiments, the sample holding chamber has a fixed depth of less than about 1 ⁇ m.
  • At least a portion of the adhesive layer is optically clear in the range of about 250 nm to about 10,000 nm in wavelength.
  • the top layer may be made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the adhesive layer may be a pressure-sensitive adhesive layer comprising a material selected from acrylic or acrylate adhesive.
  • the bottom layer may include an irradiation or thermally cured material.
  • the bottom layer comprises a UV-cured polymeric material, for example, a material selected from the group consisting of acrylate, urethane and epoxy.
  • the sample chamber further includes a backing layer that is bond to the bottom layer.
  • the backing layer may be made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the invention generally relates to a method for fabricating a sample chamber.
  • the method includes: providing an optically clear backing layer; placing uniformly an irradiation- or thermally-curable layer on the backing layer; imprinting a preformed structure mold on to the irradiation- or thermally-curable layer, wherein the preformed structured mold protruding into the irradiation- or thermal-curable layer; curing the irradiation- or thermally-curable layer by irradiation or thermal treatment; removing the preformed structure mold, thereby forming an imprinted structure in the irradiation- or thermal-cured layer reflecting the preformed structure of the mold; and placing an optically clear top film having an optically clear adhesive layer on to the imprinted structure of the irradiation- or thermally-cured layer, thereby forming a chamber having the imprinted structure.
  • the method may further include: forming one or more access port on the chamber allowing introduction and removal of a sample.
  • the optically clear backing layer is made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the irradiation layer may be made of an UV-curable material selected from the group consisting of UV-cured acrylate, urethane and epoxy.
  • the optically clear top film is made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the preformed structure mold is formed from aluminum mold.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: imprinting a preformed structure mold on to an irradiation- or thermal-curable layer, the preformed structured mold protruding into the irradiation- or thermal-curable layer; curing the irradiation- or thermal- curable layer to form an optically clear layer thereby forming a chamber having the imprinted structure; removing the preformed structure mold; binding an optically clear top film to the imprinted structure of the irradiation- or thermal-cured layer, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: imprinting a preformed structure mold on to a melt plastic layer; cooling the melt plastic layer resulting an imprinted structure thereon; removing the preformed structure mold; binding an optically clear top film to the imprinted structure, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: stamping a hot preformed structure mold on to a plastic layer, resulting an imprinted structure thereon; removing the preformed structure mold; cooling the plastic layer; binding an optically clear top film to the imprinted structure, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • FIG.1 depicts a traditional manual bacteria hemacytometer (Cole Palmer).
  • FIG.2 depicts a schematic cross-section of an exemplary sample chamber according to an embodiment of this invention.
  • FIG.3 depicts a schematic top view of an exemplary sample chamber according to an embodiment of this invention.
  • FIG.4 depicts a schematic cross-section of an exemplary sample chamber according to an embodiment of this invention.
  • FIG.5 depicts a schematic top view of an exemplary sample chamber according to an embodiment of this invention.
  • FIG.6 is a schematic depiction of a fabrication method.
  • FIG.7 depicts an aspect of an exemplary fabrication method according to the invention.
  • FIG.8 depicts an aspect of an exemplary fabrication method according to the invention.
  • FIG.9 depicts an aspect of an exemplary fabrication method according to the invention.
  • FIG.10 depicts an illustration of an exemplary laser distance measurement setup and an exemplary image obtained.
  • FIG.11 depicts an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.12 depicts an exemplary fluorescence of 2.5 ⁇ m beads using an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.13 depicts an exemplary fluorescence of 2.5 ⁇ m beads using an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.14 depicts an exemplary bright field and fluorescence of 2.5 ⁇ m beads using an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.15 depicts an exemplary of bright field image of 2 m beads using an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.16 depicts an exemplary of bright field image of yeasts and bacteria using an exemplary thin gap chamber slide according to an embodiment of the invention.
  • FIG.17 depicts an exemplary of fluorescence image of yeast and bacteria using an exemplary thin gap chamber slide according to an embodiment of the invention with the signal size presented in a cross section of the image.
  • FIG.18 depicts an exemplary of fluorescence image of yeast and bacteria using an exemplary thin gap chamber slide according to an embodiment of the invention and stained with SYTO9 (Invitrogen) instead of Acridine Orange.
  • the invention is based, in part, on the discovery of unique sample chamber designs and efficient and cost-effective fabrication and manufacturing methods that allow accurate, consistent and efficient imaging of bacteria or parasites using both bright field and fluorescent.
  • Bacteria have a wide diversity of shapes and sizes.
  • Bacterial cells typically are about one tenth the size of eukaryotic cells and are typically 0.3–5.0 micrometres in length.
  • the smallest bacteria are members of the genus Mycoplasma, which measure only 0.3 micrometres, as small as the largest viruses. Some bacteria may be even smaller.
  • Most bacterial species are either spherical or rod-shaped although other shapes do exist. Many bacterial species exist simply as single cells, others associate in characteristic patterns such as pairs, chains, and clusters. Bacteria can also be elongated to form filaments.
  • Pathogenic bacteria are a major cause of human death and disease and cause various infections such as tetanus, typhoid fever, diphtheria, syphilis, cholera, foodborne illness, leprosy and tuberculosis.
  • a significant limitation of the existing instruments and methods is that none of them provide automatic sample imaging and cell counting that are efficient and provide accurate and consistent results while at the same time are cost-effective.
  • a major reason for this limitation has been the lack of an enabling sample (or cell) chamber design and corresponding efficient and low cost fabrication and manufacturing methods.
  • the present invention provides sample chamber designs and fabrication methods that allow efficient and effective imaging of small size biological particles such bacteria or parasites using both bright field and fluorescent.
  • FIG.2 illustrates the cross section of a cell counting chamber according to an embodiment of this invention.
  • the cell counting chamber 200 has a bottom layer 210, which may be a layer of a UV-cured material.
  • a bottom layer 210 On the bottom layer 210, certain pre-designed cavity 230 is present (profiled on the top surface 215 of the bottom layer 210).
  • An optically clear adhesive layer 220 is placed between the bottom layer 210 and a top layer 240, bonding the top surface 215 of the bottom layer 210 and the bottom surface 245 of the top layer 240 (with the exception where the pre-designed cavity 230 is present).
  • at least one (and preferably two FIG.3) sample port e.g., a circular-shaped opening) is present allowing access to the cavity 230.
  • sample chamber 400 has two sample holding cavities, 432 and 438 with fixed heights h 1 and h 2 , respectively.
  • the fixed heights h 1 and h 2 may be identical or different.
  • the corresponding sample ports (FIG.5) allow introduction of samples to the two cavities individually, therefore enabling side-by-side imaging of two different samples.
  • the chamber depth could be fabricated in various ways, but the most efficient method as disclosed herein employs imprint lithography.
  • This method utilizes a mold that, when imprinted with a thermally or light cured solution, forms a pre-designed structure on a plastic sheet.
  • a unique method as disclosed herein utilizes an optical clear adhesive to cover the entire top surface that provides clear imaging capability while enclosing the chamber.
  • FIG.6 depicts an exemplary embodiment of a fabrication method according to this invention.
  • a UV-curable solution 610 is dispensed over a plastic surface 620 and a structure mold 630 is imprinted on the surface 615 of the solution 610. UV light is allowed to cure the solution 610.
  • the mold 630 is removed and the desired cavity structure 640 is formed.
  • a top layer 650 with an adhesive layer 660 is placed on top of the UV-cured layer 610 with structure 640.
  • An important aspect of the invention lies in the utilization of optically clear transfer adhesive as the enclosing layer of the thin gap chamber, which simplified the method from using an expensive and tedious ink transfer system or adhesive coating to simply laying down a top sheet to form the chamber enclosure on the molded structure.
  • the invention generally relates to a sample chamber suitable for holding a liquid sample for optical imaging.
  • the sample chamber includes: a top layer; an adhesive layer; a bottom layer; a sample holding cavity between the adhesive layer and the bottom layer having a fixed depth of from about 0.5 ⁇ m to about 1,000 ⁇ m; and an assess port for placing a sample into or out of the chamber; wherein at least a portion of the adhesive layer is optically clear in the range of about 250 nm to about 10,000 nm in wavelength, and wherein at least a portion of the top layer and the bottom layer is optically clear in the range of about 300 nm and about 10,000 nm in wavelength.
  • the bottom layer of the sample chamber further includes a base film.
  • the sample holding cavity of the sample chamber has a fixed depth of from about 1 ⁇ m to about 100 ⁇ m. In certain preferred embodiments, the sample holding cavity has a fixed depth of from about 2 ⁇ m to about 50 ⁇ m. In certain preferred embodiments, the sample holding cavity has a fixed depth of from about 2 ⁇ m to about 20 ⁇ m. In certain other preferred embodiments, the sample holding cavity has a fixed depth less than about 2 ⁇ m. In certain other preferred embodiments, the sample holding cavity has a fixed depth less than about 1 ⁇ m.
  • At least a portion of the adhesive layer is optically clear in the range of about 300 nm to about 10,000 nm in wavelength, and wherein at least a portion of the top and the bottom layers is optically clear in the range of about 300 nm and about 10,000 nm in wavelength.
  • the top layer of the sample chamber may be made of a material selected from the group consisting of polyester, polycarbonate, poly(methyl methacrylate) (PMMA), polystyrene and cyclic olefin copolymer, and other optically clear plastic films.
  • the adhesive layer of the sample chamber may be a pressure-sensitive adhesive layer that includes a material selected from acrylic or acrylate adhesive.
  • the bottom layer may include an irradiation or thermally cured material.
  • the bottom layer may be a UV-cured polymeric material.
  • the UV- cured materials are selected from the group consisting of UV-cured acrylate, urethane and epoxy.
  • the sample chamber further includes a backing layer that is bond to the bottom layer.
  • the backing layer may include a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer, and other optically clear plastic films.
  • the invention generally relates to a sample chamber suitable for holding a biological sample for optical imaging.
  • the sample chamber includes: an optically clear bottom layer; an optically clear top layer; an optically clear adhesive layer binding the top layer on one side and forming a sample holding chamber on the other side with an irradiation- or thermally-cured polymer layer, wherein the sample holding chamber having a fixed depth from the adhesive layer to the irradiation- or thermally-cured polymer layer of from about 0.5 ⁇ m to about 1,000 ⁇ m; an inlet port for introducing a sample into the chamber; and an outlet port for removing a sample from the chamber (the sample holding cavity).
  • the sample holding chamber has a fixed depth of from about 1 ⁇ m to about 100 ⁇ m. In certain preferred embodiments, the sample holding chamber has a fixed depth of from about 2 ⁇ m to about 50 ⁇ m. In certain preferred embodiments, the sample holding chamber has a fixed depth of from about 2 ⁇ m to about 20 ⁇ m. In certain other preferred embodiments, the sample holding chamber has a fixed depth of less than about 2 ⁇ m. In certain other preferred embodiments, the sample holding chamber has a fixed depth of less than about 1 ⁇ m.
  • At least a portion of the adhesive layer is optically clear in the range of about 250 nm to about 10,000 nm in wavelength.
  • the top layer may be made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the adhesive layer may be a pressure-sensitive adhesive layer comprising a material selected from acrylic or acrylate adhesive.
  • the bottom layer may include an irradiation or thermally cured material.
  • the bottom layer comprises a UV-cured polymeric material, for example, a material selected from the group consisting of acrylate, urethane and epoxy.
  • the sample chamber further includes a backing layer that is bond to the bottom layer.
  • the backing layer may be made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the invention generally relates to a method for fabricating a sample chamber.
  • the method includes: providing an optically clear backing layer; placing uniformly an irradiation- or thermally-curable layer on the backing layer; imprinting a preformed structure mold on to the irradiation- or thermally-curable layer, wherein the preformed structured mold protruding into the irradiation- or thermal-curable layer; curing the irradiation- or thermally-curable layer by irradiation or thermal treatment; removing the preformed structure mold, thereby forming an imprinted structure in the irradiation- or thermal-cured layer reflecting the preformed structure of the mold; and placing an optically clear top film having an optically clear adhesive layer on to the imprinted structure of the irradiation- or thermally-cured layer, thereby forming a chamber having the imprinted structure.
  • the method may further include: forming one or more access port on the chamber allowing introduction and removal of a sample.
  • the optically clear backing layer is made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the irradiation layer may be made of an UV-curable material selected from the group consisting of UV-cured acrylate, urethane and epoxy.
  • the optically clear top film is made of a material selected from the group consisting of polyester, polycarbonate, PMMA, polystyrene and cyclic olefin copolymer.
  • the preformed structure mold is formed from aluminum mold.
  • an adhesive is coated onto the top layer (e.g., film) for support, and the top layer and the adhesive layer together are directly applied onto the structured surface of the bottom layer to make the chamber.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: imprinting a preformed structure mold on to an irradiation- or thermal-curable layer, the preformed structured mold protruding into the irradiation- or thermal-curable layer; curing the irradiation- or thermal- curable layer to form an optically clear layer thereby forming a chamber having the imprinted structure; removing the preformed structure mold; binding an optically clear top film to the imprinted structure of the irradiation- or thermal-cured layer, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • a desired structure can be formed by thermal casting (e.g., directly on the bottom layer by casting a melting plastic onto a mold surface to form the bottom part.
  • a desired structure can be formed by thermal stamping (e.g., to thermal stamp a plastic film to form the structure). These processes only involve employ heat to "shape" a plastic material to form the needed structures on the plastic material and no chemical reaction is needed.
  • the invention also relates to sample chambers wherein the bottom layer is formed by thermal casting or thermal stamping.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: imprinting a preformed structure mold on to a melt plastic layer; cooling the melt plastic layer resulting an imprinted structure thereon; removing the preformed structure mold; binding an optically clear top film to the imprinted structure, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • the invention generally relates to a method for manufacturing a sample chamber suitable for holding a biological sample.
  • the method includes: stamping a hot preformed structure mold on to a plastic layer, resulting an imprinted structure thereon; removing the preformed structure mold; cooling the plastic layer; binding an optically clear top film to the imprinted structure, thereby forming a sample chamber; and forming one or more access port on the chamber allowing introduction and removal of a sample.
  • Samples that may be analyzed using the methods of the invention include biological materials obtained from or derived from living organisms.
  • the sample will include bacteria, parasites, cells, tissues, or biomolecules, such as proteins, polynucleotides (e.g., DNA or RNA), organic material, and any combination of the foregoing.
  • samples include, but are not limited to, hair, skin, tissue, cultured cells, cultured cell media, and body fluids.
  • a tissue is a mass of connected cells and/or extracellular matrix material, e.g., CNS tissue, neural tissue, eye tissue, liver tissue, placental tissue, mammary gland tissue, gastrointestinal tissue, musculoskeletal tissue, genitourinary tissue, and the like, derived from, for example, a human or other mammal and includes the connecting material and the liquid material in association with the cells and/or tissues.
  • a body fluid is a liquid material derived from, for example, a human or other mammal.
  • Such body fluids include, but are not limited to, blood, plasma, serum, serum derivatives, bile, phlegm, saliva, sweat, amniotic fluid, mammary fluid, and cerebrospinal fluid (CSF), such as lumbar or ventricular CSF.
  • CSF cerebrospinal fluid
  • a sample also may be media containing cells or biological material.
  • Systems of the invention can also be used to interrogate cell lines.
  • Cell lines refer to specific cells that can grow indefinitely given the appropriate medium and conditions.
  • Systems of the invention can be used to interrogate any type of cell line.
  • Cell lines can be mammalian cell lines, insect cell lines or plant cell lines.
  • Exemplary cell lines can include tumor cell lines or stem cell lines.
  • the thin gap chamber slide is shown in FIG.11.
  • the gap size using the laser position detector measured approximately 30 ⁇ m depth.
  • the laser position detector used a 532 nm green laser that is focused on to the chamber.
  • the reflection of light at different layer produced a bright light, which was used to estimate the chamber depth.
  • the fluorescence of 2.5 ⁇ m beads (linearFlow, Invitrogen) in the thin gap chamber was observed for both green and orange emission fluorescence channel.
  • FIG.12 shows the bright field (right) and fluorescence image (left) of the 2.5 m beads in a thin gap chamber for green emission.
  • FIG.13 shows the bright field (right) and fluorescence image (left) of the 2.5 m beads in a thin gap chamber for orange emission.
  • FIG.14 shows the bright field (right) and fluorescence image (left) of the 2.5 m beads in a thin gap chamber for blue emission.
  • FIG.15 shows the bright field image of 2 m beads in a fabricated thin gap chamber, to show the dispersion of beads inside the chamber.
  • the beads were observed to continuously flow for a long period of time before settling down. By taping both outlet and inlet ports with scotch tape, the settle time were reduced from about 15 min to less than about 5 min. The temperature gradient from the light did not affect the flow of beads.
  • FIG.16 Yeast and bacteria samples were imaged (FIGs.16-18) and the results demonstrate the effectiveness of the cell chamber and methods of the invention.
  • FIG.16 by utilizing 20X objective and thin gap chamber, yeasts and yogurt bacteria were simultaneously observed in the bright field image.
  • the yeasts and bacteria sample was stained with Acridine Orange (AO), which is a nuclear stain that stains all cells.
  • AO Acridine Orange
  • the fluorescence image of yeasts and bacteria is shown in FIG. 17, and the signals are shown in a cross section of the image.
  • other dyes such as SYTO9 (Invitrogen) may be used to perform the same staining quality as AO (FIG.18).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Signal Processing (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Optical Measuring Cells (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne d'une manière générale des systèmes analytiques et de surveillance utiles pour l'analyse et la mesure de cellules et d'échantillons biologiques. Plus particulièrement, l'invention concerne une chambre de numération cellulaire unique, par exemple, une chambre cellulaire fluidique à fin écartement à la fois pour l'imagerie en fond clair et par fluorescence de bactéries et de parasites, et des procédés pour les fabriquer.
EP11735090.0A 2010-01-20 2011-01-19 Chambre de comptage des cellules et d'échantillon et procédés de fabrication Active EP2526397B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29677810P 2010-01-20 2010-01-20
PCT/US2011/021676 WO2011091007A2 (fr) 2010-01-20 2011-01-19 Numération cellulaire et chambre d'échantillonnage et procédés de fabrication

Publications (3)

Publication Number Publication Date
EP2526397A2 true EP2526397A2 (fr) 2012-11-28
EP2526397A4 EP2526397A4 (fr) 2013-12-11
EP2526397B1 EP2526397B1 (fr) 2020-11-25

Family

ID=44307548

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11735090.0A Active EP2526397B1 (fr) 2010-01-20 2011-01-19 Chambre de comptage des cellules et d'échantillon et procédés de fabrication

Country Status (4)

Country Link
US (2) US8928876B2 (fr)
EP (1) EP2526397B1 (fr)
CN (1) CN102822657B (fr)
WO (1) WO2011091007A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522396B2 (en) 2010-12-29 2016-12-20 S.D. Sight Diagnostics Ltd. Apparatus and method for automatic detection of pathogens
CN104169719B (zh) 2011-12-29 2017-03-08 思迪赛特诊断有限公司 用于检测生物样品中病原体的方法和系统
EP2999988A4 (fr) 2013-05-23 2017-01-11 S.D. Sight Diagnostics Ltd. Procédé et système d'imagerie de prélèvement cellulaire
IL227276A0 (en) 2013-07-01 2014-03-06 Parasight Ltd A method and system for preparing a monolayer of cells, particularly suitable for diagnosis
US10831013B2 (en) 2013-08-26 2020-11-10 S.D. Sight Diagnostics Ltd. Digital microscopy systems, methods and computer program products
US10482595B2 (en) 2014-08-27 2019-11-19 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
CN104777101A (zh) * 2015-04-24 2015-07-15 王丹凤 一种观察细胞的方法
CN104777100A (zh) * 2015-04-24 2015-07-15 王丹凤 一种微液池的制备方法
AU2016322966B2 (en) 2015-09-17 2021-10-14 S.D. Sight Diagnostics Ltd Methods and apparatus for detecting an entity in a bodily sample
US11733150B2 (en) 2016-03-30 2023-08-22 S.D. Sight Diagnostics Ltd. Distinguishing between blood sample components
EP3455626B1 (fr) 2016-05-11 2025-08-06 S.D. Sight Diagnostics Ltd. Exécution des mesures optiques sur un échantillon
US11307196B2 (en) 2016-05-11 2022-04-19 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
US10792657B2 (en) * 2016-12-05 2020-10-06 University Of Massachusetts Microfluidic devices having top and bottom layers of graphene and a middle layer with a patterned cavity
JP6941939B2 (ja) * 2016-12-22 2021-09-29 リンテック株式会社 検査部材、および検査部材の製造方法
AU2018369859B2 (en) 2017-11-14 2024-01-25 S.D. Sight Diagnostics Ltd Sample carrier for optical measurements
CN111812834B (zh) * 2019-07-23 2026-03-06 南京九川科学技术有限公司 一种液基细胞样品的显微成像装置及显微成像方法
AU2020372024B2 (en) 2019-10-22 2026-03-12 S.D. Sight Diagnostics Ltd Accounting for errors in optical measurements
MX2022007127A (es) 2019-12-12 2022-07-11 S D Sight Diagnostics Ltd Generacion artificial de una imagen de frotis sanguineo en color.
AU2020400400B2 (en) 2019-12-12 2026-03-19 S.D. Sight Diagnostics Ltd Detecting platelets in a blood sample
BR112022011312A2 (pt) 2019-12-12 2022-08-23 S D Sight Diagnostics Ltd Análise de um analito disposto dentro de um meio
KR102474790B1 (ko) * 2020-03-17 2022-12-07 주식회사 나노엔텍 유체분석용 칩
DE102021208185A1 (de) * 2021-07-29 2023-02-02 Carl Zeiss Microscopy Gmbh Probenträger und dessen Verwendung sowie Verfahren, insbesondere zur Detektion von Pathogenen
US20260056398A1 (en) * 2022-09-07 2026-02-26 Nanoentek, Inc. Quality control slide of cell counting device, and method for manufacturing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171866A (en) * 1978-04-20 1979-10-23 Tolles Walter E Disposable volumetric slide
NL8303252A (nl) * 1983-09-22 1985-04-16 Philips Nv Optische glasvezel voorzien van een eerste en een tweede bedekking.
US4761381A (en) * 1985-09-18 1988-08-02 Miles Inc. Volume metering capillary gap device for applying a liquid sample onto a reactive surface
US6375871B1 (en) * 1998-06-18 2002-04-23 3M Innovative Properties Company Methods of manufacturing microfluidic articles
SE521120C2 (sv) * 1997-10-03 2003-09-30 Hemocue Ab Framställning av mikrokyvetter
DK172892B1 (da) * 1997-10-20 1999-09-13 Hans Degn Doseringsenhed og metode til kontinuerlig indføring af væskeopløsningsprøver i et system
DE19846958C2 (de) * 1998-08-19 2001-06-13 Fraunhofer Ges Forschung Verfahren zur Herstellung einer Einrichtung zum Transport von kleinsten Flüssigkeitsmengen
AU2003302264A1 (en) * 2002-12-20 2004-09-09 Biotrove, Inc. Assay apparatus and method using microfluidic arrays
US20040145805A1 (en) * 2003-01-16 2004-07-29 Jean Qiu Unitary device with internal microscopic counting grid used for analysis of microscopic particles contained in liquid
US7329537B2 (en) * 2003-04-17 2008-02-12 Nexcelom Bioscience, Llc Micro-pattern embedded plastic optical film device for cell-based assays
US7273659B2 (en) * 2003-12-18 2007-09-25 Lintec Corporation Photochromic film material
US7731901B2 (en) * 2005-10-19 2010-06-08 Abbott Laboratories Apparatus and method for performing counts within a biologic fluid sample
US20090273119A1 (en) * 2006-03-10 2009-11-05 Tetsuya Imai Imprint Method and Imprint Apparatus
US7737392B2 (en) * 2006-11-09 2010-06-15 The Board Of Trustees Of The University Of Illinois Photonic crystal sensors with integrated fluid containment structure, sample handling devices incorporating same, and uses thereof for biomolecular interaction analysis
JP5182470B2 (ja) * 2007-07-17 2013-04-17 大日本印刷株式会社 インプリントモールド
WO2009020982A1 (fr) * 2007-08-06 2009-02-12 The Regents Of The University Of California Appareil nano-microfluidique pour une analyse en temps réel continue de cibles dans des films liquides fins
US20100189338A1 (en) * 2008-04-09 2010-07-29 Nexcelom Bioscience Systems and methods for counting cells and biomolecules

Also Published As

Publication number Publication date
WO2011091007A2 (fr) 2011-07-28
CN102822657B (zh) 2016-01-20
US8928876B2 (en) 2015-01-06
US9186843B2 (en) 2015-11-17
EP2526397B1 (fr) 2020-11-25
WO2011091007A3 (fr) 2011-12-22
US20150183153A1 (en) 2015-07-02
US20130120747A1 (en) 2013-05-16
CN102822657A (zh) 2012-12-12
EP2526397A4 (fr) 2013-12-11

Similar Documents

Publication Publication Date Title
US9186843B2 (en) Cell counting and sample chamber and methods of fabrication
KR101362293B1 (ko) 세포배양구조체, 세포배양용기, 스페로이드를 갖는 구조체,스페로이드를 갖는 용기 및 이들의 제조방법
EP2686154B1 (fr) Système microfluidique ayant des structures monolithiques nanoplasmoniques
ES2618078T3 (es) Imagen mejorada de células raras enriquecidas inmunomagnéticamente
JP2006501860A (ja) 細胞をアッセイするための基体、装置および方法
US20090311717A1 (en) Microfluidic chip design comprising capillaries
US10048193B2 (en) Convex lens-induced confinement for measuring distributions of molecular size
US7666308B2 (en) Magnetic separation apparatus and methods
Berard et al. Precision platform for convex lens-induced confinement microscopy
JP2005245317A (ja) 微生物の計測装置及び計測方法
US8194243B2 (en) Cell tray
US11203015B2 (en) Microfluidic device
US20040145805A1 (en) Unitary device with internal microscopic counting grid used for analysis of microscopic particles contained in liquid
EP4407314A1 (fr) Système, procédé et appareil de détection de force mécanique agissant sur des cellules, et procédé de fabrication associé
CN112236451A (zh) 引起性传播疾病的细菌和免疫t细胞检测
JP4679847B2 (ja) 細胞の解析方法
US7871824B2 (en) Flow chamber
Gärtner et al. Sensor enhanced microfluidic devices for cell based assays and organs on chip
Reiser et al. Single Cell Microarrays Fabricated by Microscale Plasma-Initiated Protein Patterning (μ PIPP)
US20230203416A1 (en) High throughput migrating cell isolation retrieval device and methods of fabrication
DE10058690C1 (de) Objektträgersystem für die Labordiagnostik und Mikroskopie
US20230234056A1 (en) Microfluidic systems and methods for sorting particles
Bajwa Label-free, real-time detecting and monitoring of drug dosage and bacteria

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120718

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131108

RIC1 Information provided on ipc code assigned before grant

Ipc: B29C 43/00 20060101ALI20131104BHEP

Ipc: B29C 65/00 20060101ALI20131104BHEP

Ipc: G01N 21/64 20060101ALI20131104BHEP

Ipc: G01N 15/14 20060101ALI20131104BHEP

Ipc: B81C 3/00 20060101ALI20131104BHEP

Ipc: B01L 3/00 20060101AFI20131104BHEP

Ipc: G01N 21/03 20060101ALI20131104BHEP

Ipc: B29C 65/50 20060101ALI20131104BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190524

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602011069414

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: G01N0001280000

Ipc: G01N0021030000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 15/14 20060101ALI20200526BHEP

Ipc: B29K 33/00 20060101ALN20200526BHEP

Ipc: B29L 31/00 20060101ALN20200526BHEP

Ipc: B29K 63/00 20060101ALN20200526BHEP

Ipc: G01N 21/64 20060101ALI20200526BHEP

Ipc: G01N 21/05 20060101ALN20200526BHEP

Ipc: B29K 75/00 20060101ALN20200526BHEP

Ipc: B29C 65/48 20060101ALN20200526BHEP

Ipc: G01N 21/03 20060101AFI20200526BHEP

Ipc: B01L 3/00 20060101ALI20200526BHEP

Ipc: B29C 65/50 20060101ALI20200526BHEP

Ipc: B29C 65/00 20060101ALI20200526BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 21/64 20060101ALI20200602BHEP

Ipc: B29C 65/00 20060101ALI20200602BHEP

Ipc: G01N 21/05 20060101ALN20200602BHEP

Ipc: B29K 75/00 20060101ALN20200602BHEP

Ipc: B29K 63/00 20060101ALN20200602BHEP

Ipc: B29K 33/00 20060101ALN20200602BHEP

Ipc: G01N 21/03 20060101AFI20200602BHEP

Ipc: B29L 31/00 20060101ALN20200602BHEP

Ipc: B29C 65/50 20060101ALI20200602BHEP

Ipc: G01N 15/14 20060101ALI20200602BHEP

Ipc: B29C 65/48 20060101ALN20200602BHEP

Ipc: B01L 3/00 20060101ALI20200602BHEP

INTG Intention to grant announced

Effective date: 20200625

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1338887

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602011069414

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1338887

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201125

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210225

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210225

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602011069414

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210119

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

26N No opposition filed

Effective date: 20210826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20110119

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20260127

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20260128

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20260126

Year of fee payment: 16